CRISPR Therapeutics, Inc.

Senior Quality Control Stability Specialist

Certified, then withdrawn · decided Oct 16, 2024 · H-1B

This is a Labor Condition Application (LCA) as an employer filed it with the US Department of Labor. Certified means DOL accepted it, the step before a visa petition: it is not a visa or a hire. The wage is what the employer wrote on it. Data sources

Wage offered
$115,000 a year
Prevailing wage
$97,760 a year, level II
Worksite
Boston, MA · Boston City
Occupation
Chemists 19-2031
Full time
Yes
Positions
1
Kind
New employment
Employment
Oct 14, 2024 to Oct 13, 2027
Received
Sep 20, 2024
First certified
Sep 27, 2024
Employer
CRISPR Therapeutics, Inc.
Employer’s address
Boston, MA
FEIN
47-3173478
Industry (NAICS)
54171
H-1B dependent
No
Willful violator
No
Case number
I-200-24264-354128

From LCA_Disclosure_Data_FY2025_Q1.xlsx, row 89,442 (FY2025), published by the US Department of Labor on its Performance Data page.